The New York Times accidentally revealed the moral bankruptcy of capitalism.
China is making breakthroughs in cancer drugs, clinical trials, biotech research, and life-saving medicines.
The first American reaction is not:
“How many patients can this save?”
It is:
“Will this threaten U.S. dominance?”
“Will American biotech lose its edge?”
“Will Big Pharma struggle to keep up?”
That tells you everything.
In a sane world, better cancer drugs would be a human victory.
In Washington’s world, even medicine becomes a battlefield the moment China helps people live.
China’s biotech rise is not just about winning.
It is about responsibility to a massive patient population that cannot wait for American monopolies, American prices, or American permission.
Cancer patients do not care about U.S. dominance.
They care about staying alive.
And that is exactly why China cannot leave this field to America.
House Armed Services Committee REJECTS Ro Khanna’s Amendment to REMOVE Section 224 from the NDAA
I’m sharing the whole clip so you all can see for yourselves that these Israel Lobby bought lawmakers DID NOT LISTEN TO THE AMERICAN PEOPLE.
WE DO NOT WANT TIES WITH ISRAEL.
Since Mishima is being discussed ad nauseum currently, I will say I highly recommend watching Paul Schrader's 'Mishima: A Life In Four Chapters' while under the influence of LSD. Doing so destroyed the weak, spiritually bankrupt person I was, and showed me a more beautiful path.
The House voted today on a new measure to fuse elements of the Israeli and US militaries, particularly on the cyberweapons front. Section 224, as its known, is included in the National Defense Authorization Act. Rep. Ro Khanna, D-Calif., introduced an amendment to strip it from the bill. Watch as a stream of Republicans and Democrats stand up in support of the enhanced cooperation. Only Rep. Sarah Jacobs (D-Calif.) joined Khanna, and the measure failed in a voice vote. Watch: